Nurix legal chief sells shares to cover RSU taxes
Nurix Therapeutics, Inc. Chief Legal Officer Christine Ring had restricted stock units vest and related share movements on April 30, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nurix Therapeutics, Inc. Chief Legal Officer Christine Ring had restricted stock units vest and related share movements on April 30, 2026. She sold 3,214 shares of common stock at a weighted average of $16.6453 per share solely to cover tax withholding on the RSU vesting, under the company’s mandatory “sell to cover” policy, so the sale was not a discretionary trade. In connection with the vesting, she acquired a total of 8,608 shares of common stock through RSU conversions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 2,000 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 3,750 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 2,858 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,750 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,858 | $0.00 | $0.00 |
| Sale | Common Stock | 3,214 | $16.6453 | $53K |
Footnotes (7)
- F1. The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- F2. Represents the weighted average sale price. The lowest price at which shares were sold was $16.51 and the highest price at which shares were sold was $16.78. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- F3. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- F4. The RSUs vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2023, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting.
- F5. RSUs do not expire; they either vest or are canceled prior to the vest date.
- F6. The RSUs vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2024, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting.
- F7. The RSUs vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2025, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting.
Key Figures
Key Terms
restricted stock units ("RSUs") financial
sell to cover financial
equity incentive plans financial
weighted average sale price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Nurix (NRIX) report for Christine Ring?
How do Nurix (NRIX) restricted stock units work for Christine Ring?
AI-generated analysis. How Rhea-AI works. Not financial advice.